Spark Reda,,cents 718 anti-mouse/human CD45R/B220 [RA3-6B2]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471228
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $168.00
About this award
The University of Virginia awarded contract A207_PO-0471228 to BioLegend Inc. on August 20, 2026, for the procurement of laboratory reagents. The contract encompasses the delivery of Spark Reda anti-mouse/human CD45R/B220 [RA3-6B2] monoclonal antibodies, a single unit valued at $168. The contract amount totals $168.00, with delivery specified to Emily Whitestone at the University of Virginia in Virginia.
This procurement represents a routine purchase of research-grade immunological reagents by an academic institution. BioLegend Inc. serves as the prime contractor responsible for fulfilling this order. The line item specification indicates a single unit purchase of the referenced antibody product, which is commonly utilized in flow cytometry and immunological research applications within institutional laboratory settings. No additional contract performance period information beyond the award date of August 20, 2026, is specified in the available documentation.
Line items
| Item | Total |
|---|---|
| Spark Reda,,cents 718 anti-mouse/human CD45R/B220 [RA3-6B2] | $168.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471228?
Contract A207_PO-0471228 was awarded to BIOLEGEND INC. by University of Virginia on August 20, 2026.
How much is contract A207_PO-0471228 worth?
Its cumulative value is $168.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award